|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net (loss) income | ||
| Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: | ||
| Depreciation | ||
| Amortization of operating lease right-of-use assets | ||
| Amortization of intangible asset | ||
| Allowance for (Reversal of) expected credit loss | ||
| Deferred tax (benefit) expense | ||
| Goodwill impairment loss | ||
| Loss on disposal of equity securities | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable | ||
| Accounts receivable – related party | ||
| Contract assets | ||
| Prepaid expenses and other current assets | ||
| Accrued expenses and other liabilities | ||
| Contract liabilities | ||
| Lease liabilities | ||
| Income tax recoverable and payable | ||
| Net cash (used in) provided by operating activities | ||
| Cash flow from investing activities: | ||
| Purchase of equipment | ||
| Investment in equity securities | ||
| Acquisition of a subsidiary, net of cash acquired | ||
| Net cash used in investing activities | ||
| Cash flow from financing activities: | ||
| Advance from (Repayment to) related parties | ||
| Net proceeds from initial public offering | ||
| Payments of offering costs related to initial public offering | ||
| Contribution from a non-controlling shareholder of a subsidiary | ||
| Net cash provided by (used in) financing activities | ||
| Net (decrease) increase in cash and cash equivalents | ||
| Cash and cash equivalents at beginning of the year | ||
| Cash and cash equivalents at end of the year | ||
| Supplementary cash flows information: | ||
| Taxes paid | ||
| Listing fee paid | ||
| Non-cash investing and financing activities: | ||
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | ||
| Derecognition of operating lease right-of-use asset and related operating lease liability upon early termination of lease | ||
| Recognition of deferred initial public offering costs recorded in accrued expenses and other liabilities |
Loading...